For comments, suggestions
Created with Raphaël 2.1.0 28.07.2016 Filing date 12.10.2022 Validation fee payment 31.12.2022 (A1) Patent application published 20.11.2024 AGEPI application filing date 28.02.2025 (T2) Translation of the validated European patent

Patent validated


(210)Number of the EPO application21191711
(220)Filing date of the EPO application2016.07.28
(80)EPO patent specification publication (B)EPB nr. 34/2024, 2024.08.21
(110)EPO patent number3981792
(11)Number of the documentMD 3981792 T2
(21)Number of the applicatione 2022 1254
(71)Name(s) of applicant(s), code of the countryMACROGENICS INC., US;
(72)Name(s) of inventor(s), code of the countrySHAH Kalpana, US;
SMITH Douglas H., US;
LA MOTTE-MOHS Ross, US;
JOHNSON Leslie S., US;
MOORE Paul A., US;
BONVINI Ezio, US;
KOENIG Scott, US;
(73)Name(s) of owner(s), code of the countryMACROGENICS INC., US;
(54)Title of the inventionPd-1-binding molecules and methods of use thereof
(13)Kind-of-document code T2
(51)International Patent Classification C07K 16/28 (2006.01.01); A61K 39/00 (2006.01.01); A61K 39/395 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2022.12.31
(49)Date of publication of the translation of the validated European patent specification2025.02.28
(30)Priority201562198867 P, 2015.07.30, US; 201562239559 P, 2015.10.09, US; 201562255140 P, 2015.11.13, US; 201662322974 P, 2016.04.15, US
(74)Patent attorney(Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova
Up
/Inventions/details/3981792